Lupin receives Form 483 with 4 observations from USFDA for Pithampur Unit-2

The U.S. FDA inspected Lupin's Pithampur Unit-2 manufacturing facility from July 08 to July 17, 2025. The inspection closed with the issuance of a Form-483 with four observations.

We are addressing these observations comprehensively and will respond to the U.S. FDA within the stipulated timeframe. We uphold quality and compliance with utmost importance and are committed to be compliant with CGMP quality standards across all our facilities.

Shares of Lupin Limited was last trading in BSE at Rs. 1929.75 as compared to the previous close of Rs. 1951.35. The total number of shares traded during the day was 11708 in over 1373 trades.

The stock hit an intraday high of Rs. 1956.10 and intraday low of 1924.70. The net turnover during the day was Rs. 22709678.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 Pharmaceuticals USFDA Form483 4Observations Pithampur Unit2